Matulonis, Ursula A.
Dana-Farber Cancer Institute,
United States
2025 Rank: 25689
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1132 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25689 | 26612 |
| Total Cites | 28659 | 31890 |
| H-index | 87 | 93 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 73 | 80 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 3227 | 3555 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 11221 | 12436 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19798 | 21281 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.50 |
| Self-Citation Percentage |
10.13%
|
|
Matulonis, Ursula A.
Dana-Farber Cancer Institute,
United States
2024 Rank: 29771
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1332 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29771 | 29804 |
| Total Cites | 25271 | 28266 |
| H-index | 81 | 88 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 61 | 68 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2755 | 3064 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 9896 | 11043 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17502 | 18885 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.50 |
| Self-Citation Percentage |
10.60%
|
|
Matulonis, Ursula A.
Dana-Farber Cancer Institute,
United States
2023 Rank: 32577
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1505 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32577 | 33158 |
| Total Cites | 22039 | 24743 |
| H-index | 77 | 81 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 55 | 61 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 2338 | 2616 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 8645 | 9702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15355 | 16623 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.49 |
| Self-Citation Percentage |
10.93%
|
|
Matulonis, Ursula A.
Dana-Farber Cancer Institute,
United States
2022 Rank: 38615
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1728 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38615 | 39294 |
| Total Cites | 18571 | 20955 |
| H-index | 70 | 76 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 45 | 51 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1897 | 2151 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 7269 | 8201 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13106 | 14229 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
11.38%
|
|
Matulonis, Ursula A.
Dana-Farber Cancer Institute,
United States
2021 Rank: 42683
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1906 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42683 | 43171 |
| Total Cites | 16937 | 19060 |
| H-index | 66 | 71 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 39 | 44 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1715 | 1946 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 6627 | 7503 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12053 | 13013 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.46 |
| Self-Citation Percentage |
11.14%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.